Episode 11: Are we All Part of the GLP-1 Experiment?
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Episode 11: Are we All Part of the GLP-1 Experiment?
-
Lu par :
-
De :
À propos de ce contenu audio
GLP-1 drugs like Ozempic and Wegovy have transformed conversations around weight loss and metabolic health — but are we witnessing a medical breakthrough or participating in a massive social experiment?
In this episode, we explore how these FDA-approved drugs moved from diabetes treatment to mainstream use for weight management, reshaping medicine, ethics, and culture along the way. We discuss how science identifies new uses for existing drugs, what we’ve learned from past off-label revolutions, and why GLP-1s may be testing not just our metabolism, but our trust in modern medicine itself.
Topics include:
- How GLP-1 receptor agonists work in the brain and body
- Why appetite, reward, and dopamine matter
- The balance between scientific discovery and real-world experimentation
- What this moment reveals about how we use (and market) medicine today
Available on all streaming platforms — just search “Gopu & Zane” or visit lybrandlab.org/jospod
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment